A crucial step in assessing biocompatibility
In the medical device industry, product safety is not limited to mechanical performance or sterilization procedures. Assessing the biological safety of all medical devices that come into contact with the human body is of great importance. In this context, one of the most fundamental biocompatibility tests is the “in vitro cytotoxicity test.”
Biocompatibility assessments have become significantly more important for manufacturers, particularly since the entry into force of the European Union’s Medical Device Regulation (MDR 2017/745). In vitro cytotoxicity tests are conducted to determine whether the product has a toxic effect on cells.
What is an in vitro cytotoxicity test?
The in vitro cytotoxicity test is a laboratory analysis that evaluates the potential toxic effects of a medical device or a material used in a medical device on cell cultures.
This test examines the following parameters:
- Cell viability,
- Cell growth,
- Cell morphology,
- Cell damage
The goal is to detect at an early stage any potential damage to biological systems caused by chemical components that may be released from the product.
The Significance of the ISO 10993-5 Standard
In vitro cytotoxicity tests are generally conducted in accordance with ISO 10993-5, the standard published by the International Organization for Standardization.
This standard defines:
- test methods,
- Requirements for cell culture,
- Evaluation criteria,
- Methods for interpreting the results
The ISO 10993 series is one of the globally recognized fundamental references for assessing the biocompatibility of medical devices.
For which medical devices is it required?
The cytotoxicity test is required for many products that come into direct or indirect contact with the human body.
Examples:
- Surgical implants
- Catheter
- Injection systems
- Wound dressings
- Dental Materials
- Medical tubing
- Single-use medical devices
must be evaluated for biocompatibility during the product development process.
Test methods used
Various cytotoxicity methods may be used in accordance with ISO 10993-5.
Extraction method: The product material is extracted using suitable solvents, and the resulting extract is applied to a cell culture.
Direct contact method: The sample is brought into direct contact with the cell surface.
Agar diffusion method: The spread of the toxic effect is assessed using a layer of agar between the sample and the cells.
The test method is determined based on the product type, intended use, and material composition.
Parameters evaluated in cytotoxicity tests
The laboratory analyses examine various biological parameters:
- cell viability rate
- Cell proliferation
- Morphological changes
- Diaphragm damage
- Metabolic activity
These assessments are used to determine whether the product is safe at the cellular level.
The Role of Cytotoxicity Tests in the MDR Process
With the European Union’s MDR Regulation, the importance of biocompatibility dossiers in technical documentation has increased.
Manufacturers are expected to ensure product safety by:
- Risk analyses,
- clinical evaluations,
- chemical characterization studies,
- Biocompatibility Test Reports
prove.
As a result, cytotoxicity testing is no longer merely a laboratory analysis but has become a fundamental component of regulatory compliance.
Advantages of in vitro testing
Compared to conventional in vivo methods, in vitro tests offer numerous advantages:
- Faster results
- Lower costs
- An ethically sound approach
- High reproducibility
- Standardized analytical methods
With the growing prevalence of alternative testing methods, in vitro analyses are becoming increasingly important in the medical device industry.